Banco BTG Pactual’s Solid Biosciences SLDB Stock Holding History

Banco BTG Pactual’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-715	Closed	-$26K	–	96
2021 Q3	$26K	Hold	715	–	–	0.01%	104
2021 Q2	$39K	Hold	715	–	–	0.03%	92
2021 Q1	$59K	Buy	+715	New	+$79.1K	0.02%	108

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banco BTG Pactual's SLDB Position: Q4 2021 in Review

Banco BTG Pactual sold out of Solid Biosciences (SLDB) in Q4 2021, closing a stake of 715 shares — an estimated $26K sold.

Banco BTG Pactual first reported a position in SLDB in Q1 2021 and held it in 3 quarters. The position peaked at $59K in Q1 2021. 82 funds tracked by Wall St. Rank hold SLDB as of Q4 2021.

Banco BTG Pactual reported no remaining Solid Biosciences position as of Q4 2021 after selling out during the quarter.
Banco BTG Pactual sold 715 Solid Biosciences shares in Q4 2021, an estimated $26K.
Banco BTG Pactual first reported a position in Solid Biosciences in Q1 2021 and held it in 3 quarters.
Banco BTG Pactual's Solid Biosciences position peaked at $59K in Q1 2021.
82 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2021.

Based on Banco BTG Pactual's 13F filing for Q4 2021, filed 12 May 2022.